| Literature DB >> 5005719 |
M Chan-Yeung, J Morton, S Grzybowski.
Abstract
The result of a double-blind crossover trial with disodium cromoglycate (Intal) in 22 patients, nine with extrinsic asthma and 13 with intrinsic asthma, is reported. While eight extrinsic asthmatics showed considerable symptomatic improvement, only five of the intrinsic group improved while on disodium cromoglycate. Twelve out of 13 patients with symptomatic improvement had associated decrease in airway obstruction as measured by the FEV(1).It is concluded that disodium cromoglycate is useful in the treatment of asthma, particularly of the extrinsic type.Entities:
Mesh：
Substances：
Year: 1971 PMID： 5005719 PMCID： PMC1931207
Source DB: PubMed Journal: Can Med Assoc J ISSN： 0008-4409 Impact factor: 8.262